Global Plant Biotechnology Market Trends and Insights
Global Food-security and Crop-productivity Requirements
Food security and the need to improve crop productivity are driving demand for plant biotechnology solutions. The International Service for the Acquisition of Agri-biotech Applications (ISAAA) reported in February 2026 that 73 countries had adopted biotech crops through cultivation or imports. Developing countries accounted for 57% of global biotech crop hectares in 2024, highlighting the growing role of biotechnology in improving crop productivity and resilience. This is supporting demand for region-specific breeding programs and biotechnology solutions tailored to local food-security needs.Climate-resilient Crop Development
Climate adaptation is increasing demand for plant biotechnology focused on drought, heat, and salinity tolerance. These traits are often more complex to develop than single-gene traits, increasing the need for advanced breeding and gene-editing technologies. Public-sector programs, including initiatives in India, are also advancing stress-tolerant crops such as wheat, rice, and pulses. These efforts are expanding the application of biotechnology to climate-resilient crop development, particularly in regions exposed to increasing climate-related agricultural pressures.Lengthy Approval and Commercialization Timelines
Approval timelines can constrain investment decisions across the plant biotechnology market. Conventional genetically modified organism (GMO) approvals may require biosafety, food safety, environmental, and import reviews across multiple jurisdictions. A 2025 peer-reviewed article in the Trends in Plant Science journal noted that non-transgenic edited crops can move through newer regulatory pathways more quickly than products assessed under legacy GMO systems. The European Union's new framework does not fully apply until July 2028, creating a transition period that can complicate product planning. Several African and Southeast Asian countries still use legacy systems where a specific regulatory pathway for gene-edited crops is unavailable. Separate dossiers for multiple countries add costs and can delay market access in regions where food security and climate-related needs are pressing.Other drivers and restraints analyzed in the detailed report include:
- Adoption of Biotech Seeds and Stacked Traits
- Expansion of Biological Crop-protection and Nutrition Products
- High Research and Development, and Field-trial Costs
Segment Analysis
Biotech seeds and traits accounted for 65.0% of the plant biotechnology market share by product type in 2025. This position reflects decades of deployment in corn, soybean, cotton, and canola. Seed products capture value from established germplasm, regulatory approvals, and repeated planting cycles. Multi-trait seed offerings add value where farms require several weed, insect, or disease management functions. The plant biotechnology industry relies on these seed systems as its main commercial channel. Synthetic biology-enabled products remain at an earlier commercial stage, attracting investment for specialty flavors, industrial biochemicals, fermentation-derived crop inputs, and other applications outside conventional seed markets. Their longer-term role depends on manufacturing scale, product performance, and customer acceptance. These products offer a way to extend biotechnology into specialized value chains.Crop protection and nutrition solution products are forecast to grow at a CAGR of 6.3% from 2026 to 2031. This growth reflects limits on some synthetic inputs and greater interest in biological alternatives. Biological insecticides, biofertilizers, and biostimulants support growers seeking broader input choices. BASF completed its acquisition of AgBiTech in March 2026, adding biological insect-control capabilities with manufacturing in the United States, Australia, and Brazil. This transaction indicates that biological products are becoming part of large agricultural portfolios. Product adoption still depends on field consistency, local advice, and reliable supply. The category complements rather than replaces the larger seed-and-traits base, and gives the plant biotechnology market a way to serve grower input needs outside the seed purchase cycle.
Genetic engineering accounted for 42.0% of the plant biotechnology market size by technology in 2025. Its commercial role is supported by established transformation pipelines, event libraries, seed systems, and regulatory records. Marker-assisted breeding, tissue culture, synthetic biology, and speed breeding offer alternative or complementary approaches. Speed breeding can shorten plant generation cycles, helping breeders move traits through programs more quickly. Each method has different strengths in discovery, validation, and product development. Genetic engineering remains important for traits that require defined genetic changes. The existing knowledge base also supports stewardship and regulatory management for established crops. These advantages keep the technology central even as new tools gain attention. The plant biotechnology market retains this established technical base as developers evaluate newer methods.
Genome editing is forecast to grow at a CAGR of 12.4% from 2026 to 2031. It provides developers a way to make targeted changes that may be assessed differently from transgenic products in some jurisdictions. Japan's notification framework for plants without novel DNA insertions has supported the commercial introduction of gamma-aminobutyric acid (GABA)-enriched tomato. India's work on stress-tolerant staple crops broadens the potential application. The 2026 European framework may add another route for eligible products after July 2028. The plant biotechnology industry can use platform licensing to make editing capabilities available beyond major row crops. Scientific progress does not remove the need for crop-specific regeneration, field testing, and product stewardship. The technology's growth therefore depends on both technical delivery and clear country-level requirements.
Complete Report Scope:
- By Product Type
- Crop Protection and Nutrition Solution Products
- Biotech Seeds and Traits
- Synthetic Biology-Enabled Products
- By Technology
- Genetic Engineering
- Genome Editing
- Marker-Assisted Breeding
- Tissue Culture
- Synthetic Biology
- Speed Breeding
- By Crop Type
- Cereals and Grains
- Oilseeds and Pulses
- Fruits and Vegetables
- Fiber, Sugar and Specialty Crops
- By End User
- Seed Companies
- Agricultural Input Suppliers
- Agricultural Producers
- Food and Beverage Companies
- Biofuel and Biochemical Companies
- Pharmaceutical and Biopharmaceutical Companies
- Government and Research Institutes
- By Geography
- North America
- United States
- Canada
- Mexico
- Rest of North America
- South America
- Brazil
- Argentina
- Rest of South America
- Europe
- Germany
- France
- United Kingdom
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Turkiye
- Saudi Arabia
- United Arab Emirates
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Nigeria
- Kenya
- Rest of Africa
- North America
Geography Analysis
North America accounted for 41.0% of the plant biotechnology market share by geography in 2025. The region benefits from high adoption of genetically engineered (GE) crops, established seed distribution networks, and mature regulatory institutions. The United States Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) deregulated Bayer and Monsanto's MON 87429 corn in August 2026. The corn event is engineered for tolerance to dicamba, glufosinate, quizalofop, and 2,4-D, with tissue-specific glyphosate resistance. The regulatory action supports the development and potential commercialization of multi-herbicide-tolerant corn. Canada provides a complementary approval route for eligible gene-edited plants, while Mexico's regulatory environment remains closely linked to agricultural biotechnology policies across North America.Africa is forecast to expand at a 9.4% CAGR between 2026 and 2031. The continent has biotech crop activity across 10 countries and 6 approved crop types, including cotton, maize, soybean, cowpea, cassava, and potato. ISAAA AfriCenter launched its Biotech Africa platform in June 2026 to improve regulatory transparency and country-level approval information. African crop systems create demand for solutions suited to cassava, millet, cowpea, and other locally important staples. Public research, capacity building, and seed distribution determine whether approved varieties can reach farmers. The region's growth depends on coordinated biosafety frameworks, local trials, and commercial multiplication capacity. These factors make Africa a significant opportunity for crop-specific biotechnology programs. Growth in the plant biotechnology market in the region depends on solutions designed for local crops and farm conditions.
Asia-Pacific has strong growth potential, supported by regulatory activity and large crop production systems. China planted 3 million hectares of genetically engineered corn in 2025, a fourfold increase from 2024, according to United States Department of Agriculture Foreign Agriculture Service. Japan, India, South Korea, and Australia present a mix of active research programs and emerging commercialization routes. South America benefits from Brazil's large soybean production base. In August 2025, Brazil received a licensing agreement for a nematode-resistant soybean trait. In Europe, Regulation (EU) 2026/1388 begins implementation in July 2028 for most provisions. The Middle East combines Israel's genomics capabilities with broader food-security programs.
List of Companies Covered in this Report:
- Bayer AG
- Corteva, Inc.
- Syngenta Group Co., Ltd. (Sinochem Holdings Corporation Ltd.)
- BASF SE
- KWS SAAT SE & Co. KGaA
- Sumitomo Chemical Co., Ltd.
- Nufarm Limited
- Groupe Limagrain Cooperative Agricole
- DLF Seeds A/S (Dansk Landbrugs Frøselskab AmbA)
- ProFarm Group Inc. (Bioceres Crop Solutions Corp.)
- Evogene Ltd.
- Inari Agriculture, Inc.
- Pairwise Plants, LLC
- Cibus, Inc.
- Indigo Ag, Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Corteva, Inc.
- Syngenta Group Co., Ltd. (Sinochem Holdings Corporation Ltd.)
- BASF SE
- KWS SAAT SE & Co. KGaA
- Sumitomo Chemical Co., Ltd.
- Nufarm Limited
- Groupe Limagrain Cooperative Agricole
- DLF Seeds A/S (Dansk Landbrugs Frøselskab AmbA)
- ProFarm Group Inc. (Bioceres Crop Solutions Corp.)
- Evogene Ltd.
- Inari Agriculture, Inc.
- Pairwise Plants, LLC
- Cibus, Inc.
- Indigo Ag, Inc.

